|
ZCCHC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.570600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.657200E-01 |
| Normal-vs-Stage2 |
4.357000E-01 |
| Normal-vs-Stage3 |
2.593800E-01 |
| Normal-vs-Stage4 |
4.761400E-01 |
| Stage1-vs-Stage2 |
4.254000E-01 |
| Stage1-vs-Stage3 |
3.351200E-01 |
| Stage1-vs-Stage4 |
5.134600E-01 |
| Stage2-vs-Stage3 |
1.457990E-01 |
| Stage2-vs-Stage4 |
2.416400E-01 |
| Stage3-vs-Stage4 |
9.786200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.826400E-01 |
| Normal-vs-AfricanAmerican |
6.125400E-01 |
| Normal-vs-Asian |
4.113200E-01 |
| Caucasian-vs-AfricanAmerican |
7.643200E-01 |
| Caucasian-vs-Asian |
6.708000E-01 |
| AfricanAmerican-vs-Asian |
7.256200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.000600E-01 |
| Normal-vs-Female |
3.323200E-01 |
| Male-vs-Female |
8.485700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.139800E-01 |
| Normal-vs-Extreme_Weight |
2.616000E-01 |
| Normal-vs-Obese |
6.326200E-01 |
| Normal-vs-Extreme_Obese |
8.839000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.758600E-01 |
| Normal_Weight-vs-Obese |
1.290980E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.179200E-01 |
| Extreme_Weight-vs-Obese |
1.443990E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.056600E-01 |
| Obese-vs-Extreme_Obese |
9.269000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.573600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.905400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.431170E-01 |
| Normal-vs-Age(81-100Yrs) |
9.817900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.946400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.310400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.602100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.055400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.164620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.649400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.707800E-01 |
| Normal-VS-Type2 PRCC |
8.863800E-02 |
| Normal-VS-KIRP CIMP |
1.209410E-01 |
| Normal-VS-Unclassified PRCC |
4.442400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.973800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.290500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.426000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.563530E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.824200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.651600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.518400E-02 |
| Normal-vs-N1 |
4.575200E-01 |
| Normal-vs-N2 |
2.758800E-01 |
| N0-vs-N1 |
4.434400E-01 |
| N0-vs-N2 |
8.923600E-01 |
| N1-vs-N2 |
6.515600E-01 |
|
|
